Stren & Blan Partners
  • Home
  • About Us
  • Practice Areas
    • Arbitration & Litigation
    • Banking & Finance
    • Capital Markets
    • Company Secretarial Services
    • Data Protection
    • Energy
    • Immigration
    • Insolvency & Asset Recovery
    • Infrastructure
    • Intellectual Property
    • Labour & Employment
    • Mergers & Acquisition
    • Maritime & Aviation
    • Private Equity
    • Product & Professional Liability
    • Real Estate & Construction
    • Tax
    • Technology, Media & Entertainment
    • White Collar Crime & Investigation
  • Our People
  • Sectors
    • Energy & Infrastructure Sector
    • Fast Moving Consumer Goods
    • Financial Sector
    • Health & Pharmaceutical Sector
    • Technology, Media, Sports & Entertainment
    • Transportation Sector
  • News & Insights
  • Contact
Select Page
THE HEALTH AND PHARMACEUTICAL SECTOR QUARTERLY ROUND-UP FOR Q3 2025

THE HEALTH AND PHARMACEUTICAL SECTOR QUARTERLY ROUND-UP FOR Q3 2025

by Stren & Blan Partners | Oct 14, 2025 | Health and Pharmaceutical, Insight

The third quarter of 2025 was a notable period in Nigeria’s health and pharmaceutical trajectory, characterised by a sequence of reforms designed to enhance structural efficiency and restore investor confidence. Central to this evolving transformation was the...
TEMS SECTOR QUARTERLY INSIGHTS (JULY – SEPTEMBER 2025)

TEMS SECTOR QUARTERLY INSIGHTS (JULY – SEPTEMBER 2025)

by Stren & Blan Partners | Oct 10, 2025 | Insight, Technology, Media, Sport and Entertainment Sector

The July–September 2025 edition of the TEMS Sector Quarterly Insights captures key shifts across Technology, Entertainment, Media, and Sports in Nigeria and Africa. This quarter has been defined by stronger regulatory assertiveness, rising global competition, and...
STREN & BLAN PARTNERS QUARTERLY IP NEWSLETTER (JULY-SEPTEMBER)

STREN & BLAN PARTNERS QUARTERLY IP NEWSLETTER (JULY-SEPTEMBER)

by Stren & Blan Partners | Oct 2, 2025 | Insight

The third quarter of 2025 saw notable developments across Nigeria’s intellectual property (IP) and regulatory space. The Trademarks Registry introduced manual protocols to address ongoing challenges with its online filing system, while the Patents and Trademarks...
STRENGTHENING NIGERIA AS A SEAT FOR ARBITRATION: LESSONS FROM THE UNITED KINGDOM (UK) ARBITRATION ACT 2025

STRENGTHENING NIGERIA AS A SEAT FOR ARBITRATION: LESSONS FROM THE UNITED KINGDOM (UK) ARBITRATION ACT 2025

by Stren & Blan Partners | Sep 23, 2025 | Dispute Resolution, Insight

In the United Kingdom (UK), the Arbitration Act 2025 (the UK Act), which received Royal Assent on 24 February 2025 and came into force on 1 August 2025, introduced refined amendments to the Arbitration Act 1996 (the 1996 Act). These amendments clarify unclear...
FROM LAB TO GLOBAL MARKET: NAVIGATING LEGAL RISKS AND CROSS-BORDER PATENT CHALLENGES IN LICENSING LIFE SCIENCES INTELLECTUAL PROPERTY

FROM LAB TO GLOBAL MARKET: NAVIGATING LEGAL RISKS AND CROSS-BORDER PATENT CHALLENGES IN LICENSING LIFE SCIENCES INTELLECTUAL PROPERTY

by Stren & Blan Partners | Sep 22, 2025 | Insight, Intellectual Property

The journey of a life sciences invention from laboratory discovery to global commercialization is fraught with both opportunities and risks. From pharmaceuticals and biotechnology to medical devices, the life sciences sector is one of the most heavily regulated and...
FREQUENTLY ASKED QUESTIONS ON PUBLIC-PRIVATE PARTNERSHIP IN THE HEALTH AND PHARMACEUTICAL SECTOR

FREQUENTLY ASKED QUESTIONS ON PUBLIC-PRIVATE PARTNERSHIP IN THE HEALTH AND PHARMACEUTICAL SECTOR

by Stren & Blan Partners | Sep 18, 2025 | Health and Pharmaceutical, Insight

Public-Private Partnerships (PPPs) are becoming an increasingly important mechanism for financing, building, and operating healthcare infrastructure and services in Nigeria. With government budgets stretched and demand for quality healthcare rising, PPPs offer a way...
« Older Entries
Next Entries »
© Copyright 2022 Stren & Blan. All Rights Reserved.